Shares of Vanda Pharmaceuticals Inc. (VNDA) surged over 40% on Wednesday morning after the U.S. Food and Drug Administration approved Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
FDA approves Fanapt for bipolar disorder in adults healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
The approval was based on data from a phase 3 study that included approximately 400 adults with a history of bipolar I disorder who had a current episode of mania.
Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.